Helix Launches DeFi Derivatives Trading Offering with KYC Processing

Helix, the premier decentralized orderbook exchange built on Injective, today announces the launch of Helix Institutional, enabling the trading of DeFi derivatives products in a permissioned, KYC-enabled environment.

This initiative aims to usher in a new era of decentralized trading for institutions, allowing them to access the benefits of a decentralized exchange (DEX) while adhering to regulatory frameworks. Within Helix Institutional, all markets will be permissioned, meaning that only whitelisted addresses that have passed KYC guidelines can interact and trade with one another.

Helix utilizes Injective, an L1 built specifically for finance, in order to operate its DEX.

The development of Helix Institutional arrives as demand for permissioned and compliant DeFi applications continues to rise. After the historic collapse of centralized finance exchanges such as FTX and lenders such as Genesis, more institutions are beginning to flock towards DeFi in order to ensure that they maintain custody over their assets, while retaining on-chain transparency.

Helix Institutional will take advantage of this familiar environment to enable larger financial entities to swiftly adapt and seize opportunities within the realm of DeFi, while still ensuring they meet the necessary regulatory requirements. Furthermore, Helix Institutional offers institutions the opportunity to capitalize on a wide-array of featured offerings, specifically including advanced order types, leverage and access to cross-chain assets.

"True on-chain trading will fundamentally reshape the world of traditional finance as we know it," said Chris Choi, Product Lead at Helix. "Helix Institutional sets the stage for sophisticated parties to enter DeFi in a permissioned manner that was previously not possible. In turn, both on-chain capital inflows and usage can begin to rise in unison."

(Source: Finextra)